No Data
Top Midday Decliners
Cocrystal Pharma Shares Fall After Flu-Treatment Study Is Extended
Cocrystal Pharma Plans To Extend Phase 2a Influenza Challenge Study With Oral PB2 Inhibitor CC-42344 Due To Low Influenza Infection Among Challenged Participants
Express News | Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study With Oral PB2 Inhibitor Cc-42344
Express News | Cocrystal Pharma Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Q3 Earnings Beat Reported on Wednesday
Noble Financial Maintains Cocrystal Pharma(COCP.US) With Buy Rating, Maintains Target Price $10
AddiBee0925 : Hey Jag. Just a heads up. If all goes as planned, the launch for SIDU and SpaceX is on the schedule for this Friday on the 20th. I wouldn't think that it would be rescheduled so soon to the launch, at least no report has said otherwise.
Jaguar8 OP AddiBee0925 : Yes. But there might be a build up of the price before the launch just like LUNR. Hopefully it goes well.
AddiBee0925 Jaguar8 OP : yeah I'm thinking the same
Jaguar8 OP browny_440 : TNXP will be good if FDA releases decision soon
72306783 : I would like to ask, what signals or standards do you use to start building positions? I am still learning... Thank you very much for your Share
View more comments...